APIGENEX. is a Contract Service company operating in the pharmaceutical industry.
APIGENEX is a growing CRO located in Prague, Czech Republic (EU) more then 25 years. We provides high quality services in (pre)clinical development in complete package in the areas as Organic Synthesis, Peptides, Peptidomimetics, PNA Combinatorial Libraries, Analytical Chemistry, Upscale, transfer and development of clinical batches under cGMP and API production including Experimental Pharmacology on rodent models under GLP. We have close partnership with Novo Nordisk Denmark in the research of treatments for diabetetes, obesity, metabolic syndrom, toxicology.
Company type
Contract Service
Products and services
APIs (Active Pharmaceutical Ingredients), Contract Services – Analytical & Lab Services
Markets
Oceania, North America (USA, Canada), Africa, Middle East Region (e.g. UAE), Central America (e.g. Mexico), East Asia (e.g. China, Japan, Korea), Europe – EU countries, Europe – non EU (e.g. UK, Russia, ex-CIS countries), South America (e.g. Brazil, Colombia), South Asia (e.g. India, Pakistan, Sri Lanka), South East Asia (e.g. Thailand, Philippines, Singapore)
Address
APIGENEX., Podebradska 173/5, Prague, Czech Republic, 19000
